메뉴 건너뛰기




Volumn 67, Issue 5, 2008, Pages 743-775

Do off-label drug practices argue against FDA efficacy requirements? A critical analysis of physicians' argumentation for initial efficacy requirements: Featured articles

Author keywords

[No Author keywords available]

Indexed keywords


EID: 57349180914     PISSN: 00029246     EISSN: 15367150     Source Type: Journal    
DOI: 10.1111/j.1536-7150.2008.00597.x     Document Type: Article
Times cited : (11)

References (37)
  • 1
    • 57349190717 scopus 로고    scopus 로고
    • Abigail Alliance v. Eschenbach. 370 U.S. App. D.C. 391, 445 F. 3d470, 2006 U.S. App. LEXIS 10874.
    • Abigail Alliance v. Eschenbach 2006). 370 U.S. App. D.C. 391, 445 F. 3d470, 2006 U.S. App. LEXIS 10874.
    • (2006)
  • 2
    • 57349131261 scopus 로고    scopus 로고
    • Risky Rx: A Knight Ridder Investigation
    • November
    • Adams, C. A. Young 2003 Risky Rx: A Knight Ridder Investigation Knight Ridder Newspapers November 2 4.
    • (2003) Knight Ridder Newspapers , pp. 2-4
    • Adams, C.1    Young, A.2
  • 8
    • 0027179396 scopus 로고
    • Off-Label Drug Prescription: Filling the Regulatory Vacuum
    • Christopher, W. L. (1993 Off-Label Drug Prescription: Filling the Regulatory Vacuum Food and Drug Law Journal 48 : 247 262.
    • (1993) Food and Drug Law Journal , vol.48 , pp. 247-262
    • Christopher, W.L.1
  • 9
    • 57349127963 scopus 로고    scopus 로고
    • Competitive Enterprise Institute. Washington, DC: Competitive Enterprise Institute.
    • Competitive Enterprise Institute 2007). A National Survey of Orthopedic Surgeons Regarding the Food and Drug Administration and the Availability of New Therapies. Washington, DC : Competitive Enterprise Institute.
    • (2007)
  • 10
    • 57349166090 scopus 로고    scopus 로고
    • Uncertainty in Drug Development: Approval Success Rates for New Drugs
    • In. ed. Ed. A. Cato. L. Sutton. New York: Marcel Dekker.
    • nd ed. Ed. A. Cato L. Sutton. New York : Marcel Dekker.
    • (2002) nd
    • Dimasi, J.A.1
  • 11
    • 0037374498 scopus 로고    scopus 로고
    • The Price of Innovation: New Estimates of Drug Development Costs
    • DiMasi, J. A., R.W. Hansen H. G. Grabowski 2003 The Price of Innovation: New Estimates of Drug Development Costs Journal of Health Economics 22 (2 151 185.
    • (2003) Journal of Health Economics , vol.22 , Issue.2 , pp. 151-185
    • Dimasi, J.A.1    Hansen, R.W.2    Grabowski, H.G.3
  • 13
    • 57349186183 scopus 로고
    • Washington, DC: American Enterprise Institute.
    • Grabowski, H. G. J. M. Vernon 1983). The Regulation of Pharmaceuticals: Balancing the Benefits and the Risks. Washington, DC : American Enterprise Institute.
    • (1983)
    • Grabowski, H.G.1    Vernon, J.M.2
  • 14
    • 0003286945 scopus 로고
    • Health Claims in Food Marketing: Evidence on Knowledge and Behavior in the Cereal Market
    • Ippolito, P. M. A. D. Mathios 1991 Health Claims in Food Marketing: Evidence on Knowledge and Behavior in the Cereal Market Journal of Public Policy and Marketing 10 (1 15 32.
    • (1991) Journal of Public Policy and Marketing , vol.10 , Issue.1 , pp. 15-32
    • Ippolito, P.M.1    Mathios, A.D.2
  • 15
    • 0029295254 scopus 로고
    • Information and Advertising: The Case of Fat Consumption in the United States
    • Ippolito, P. M. A. D. Mathios 1995 Information and Advertising: The Case of Fat Consumption in the United States American Economic Review 85 (2 91 95.
    • (1995) American Economic Review , vol.85 , Issue.2 , pp. 91-95
    • Ippolito, P.M.1    Mathios, A.D.2
  • 16
    • 57349089497 scopus 로고    scopus 로고
    • Washington, DC: Federal Trade Commission.
    • Ippolito, P. M. J. K. Pappalardo 2002). Advertising Nutrition and Health: Evidence from Food Advertising, 1977-1997. Washington, DC: Federal Trade Commission.
    • (2002)
    • Ippolito, P.M.1    Pappalardo, J.K.2
  • 17
    • 57349199893 scopus 로고
    • Statement Before the Subcommittee on Health and the Environment: House Committee on Energy and Commerce, February 8.
    • Jaffe, S. Y. (1994). Statement Before the Subcommittee on Health and the Environment: House Committee on Energy and Commerce, February 8.
    • (1994)
    • Jaffe, S.Y.1
  • 18
    • 57349166918 scopus 로고    scopus 로고
    • Off-Label Drug Use and the FDA: Review of Supplemental Drug Applications. Testimony by the American Academy of Pediatrics Before the Subcommittee on Human Resources and the Intergovernmental Relations Government Reform and Oversight Committee, U.S. House of Representatives, September 12.
    • Kauffman, R. (1996). Off-Label Drug Use and the FDA: Review of Supplemental Drug Applications. Testimony by the American Academy of Pediatrics Before the Subcommittee on Human Resources and the Intergovernmental Relations Government Reform and Oversight Committee, U.S. House of Representatives, September 12.
    • (1996)
    • Kauffman, R.1
  • 19
    • 0029295242 scopus 로고
    • Regulating Information about Aspirin and the Prevention of Heart Attack
    • Keith, A. (1995 Regulating Information About Aspirin and the Prevention of Heart Attack American Economic Review 85 (2 96 99.
    • (1995) American Economic Review , vol.85 , Issue.2 , pp. 96-99
    • Keith, A.1
  • 20
    • 0006688609 scopus 로고
    • Regulating the Prescribing of Human Drugs for Nonapproved Uses under the Food, Drug, and Cosmetic Act
    • Kessler, D. (1978 Regulating the Prescribing of Human Drugs for Nonapproved Uses Under the Food, Drug, and Cosmetic Act Harvard Journal on Legislation 15 (4 693 760.
    • (1978) Harvard Journal on Legislation , vol.15 , Issue.4 , pp. 693-760
    • Kessler, D.1
  • 21
    • 3543144620 scopus 로고    scopus 로고
    • The Demand for and Supply of Assurance
    • In. Eds. T. Cowen. E. Crampton. Cheltenham, UK: Edward Elgar.
    • Klein, D. B. (2002 The Demand for and Supply of Assurance In Market Failure or Success: The New Debate. Eds. T. Cowen E. Crampton. Cheltenham, UK : Edward Elgar.
    • (2002) Market Failure or Success: The New Debate.
    • Klein, D.B.1
  • 23
    • 0019860207 scopus 로고
    • Persuasion or Information? the Economics of Prescription Drugs Advertising
    • Leffler, K. B. (1981 Persuasion or Information? The Economics of Prescription Drugs Advertising Journal of Law and Economics 24 (1 45 74.
    • (1981) Journal of Law and Economics , vol.24 , Issue.1 , pp. 45-74
    • Leffler, K.B.1
  • 24
    • 57349120800 scopus 로고
    • Promotion of Drugs and Medical Devices for Unapproved Uses: Hearing Before the Human Resources and Intergovernmental Relations Subcommittee of the House Comittee or Government Operations, 102 Cong., 1 Sess. 103.
    • Lundberg, G. (1991). Promotion of Drugs and Medical Devices for Unapproved Uses: Hearing Before the Human Resources and Intergovernmental Relations Subcommittee of the House Comittee or Government Operations, 102 Cong., 1 Sess. 103.
    • (1991)
    • Lundberg, G.1
  • 26
    • 57349130112 scopus 로고
    • The Serotonin Uptake Inhibitor, Fluoxetine, Reduced Alcohol Consumption in Problem Drinkers
    • Suppl
    • Naranjo, C. A., E. M. Sellers, P. Sanhueza, et al 1988 The Serotonin Uptake Inhibitor, Fluoxetine, Reduced Alcohol Consumption in Problem Drinkers Psychopharmacology 96 (Suppl 311.
    • (1988) Psychopharmacology , vol.96 , Issue.311
    • Naranjo, C.A.1    Sellers, E.M.2    Sanhueza, P.3    Al, E.4
  • 27
    • 0001022649 scopus 로고
    • An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments
    • Rpt. in G. J. Stigler (ed.) (1988) Chicago Studies in Political Economy. Chicago: University of Chicago Press.
    • Peltzman, S. (1973 An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments Journal of Political Economy 81 (5 1049 1091. Rpt. in G. J. Stigler (ed.) (1988) Chicago Studies in Political Economy. Chicago: University of Chicago Press.
    • (1973) Journal of Political Economy , vol.81 , Issue.5 , pp. 1049-1091
    • Peltzman, S.1
  • 28
    • 0027956440 scopus 로고
    • Are Pharmaceutical Ads Deceptive?
    • Rubin, P. H. (1994 Are Pharmaceutical Ads Deceptive? Food and Drug Law Journal 49 (1 7 19.
    • (1994) Food and Drug Law Journal , vol.49 , Issue.1 , pp. 7-19
    • Rubin, P.H.1
  • 29
    • 3543095487 scopus 로고
    • FDA Advertising Restrictions: Ignorance is Death
    • In. Ed. R. Higgs. Oakland, CA. Independent Institute.
    • Rubin, P. H. (1995 FDA Advertising Restrictions: Ignorance is Death In Hazardous to Our Health? FDA Regulation of Health Care Products. Ed. R. Higgs. Oakland, CA Independent Institute.
    • (1995) Hazardous to Our Health? FDA Regulation of Health Care Products.
    • Rubin, P.H.1
  • 31
    • 34250713714 scopus 로고
    • Limiting Physician Freedom to Prescribe a Drug for Any Purpose: The Need for FDA Regulation
    • Shapiro, S. A. (1979 Limiting Physician Freedom to Prescribe a Drug for Any Purpose: The Need for FDA Regulation Northwestern University Law Review 73 (5 801 872.
    • (1979) Northwestern University Law Review , vol.73 , Issue.5 , pp. 801-872
    • Shapiro, S.A.1
  • 33
    • 0012040756 scopus 로고    scopus 로고
    • Assessing the FDA Via the Anomaly of Off-Label Drug Prescribing
    • Tabarrok, A. (2000 Assessing the FDA Via the Anomaly of Off-Label Drug Prescribing Independent Review V (1 25 53.
    • (2000) Independent Review , vol.5 , Issue.1 , pp. 25-53
    • Tabarrok, A.1
  • 34
    • 57349123758 scopus 로고    scopus 로고
    • The Blessed Monopolies
    • Winter
    • Tabarrok, A. (2001 The Blessed Monopolies Regulation Winter : 1 4.
    • (2001) Regulation , pp. 1-4
    • Tabarrok, A.1
  • 35
    • 0019954649 scopus 로고
    • Use of Approved Drugs for Unlabeled Indications
    • U.S. Food, and Drug Administration
    • U.S. Food, and Drug Administration 1982 Use of Approved Drugs for Unlabeled Indications Food and Drug Administration Bulletin 12 : 4 5.
    • (1982) Food and Drug Administration Bulletin , vol.12 , pp. 4-5
  • 36
    • 33750579976 scopus 로고    scopus 로고
    • United States' Trends and Regional Variations in Lumbar Spine Surgery: 1992-2003
    • Weinstein, J. N., J. D. Lurie, P. R. Olson, K. K. Bronner E. S. Fisher 2006 United States' Trends and Regional Variations in Lumbar Spine Surgery: 1992-2003 Spine 31 (23 2707 2714.
    • (2006) Spine , vol.31 , Issue.23 , pp. 2707-2714
    • Weinstein, J.N.1    Lurie, J.D.2    Olson, P.R.3    Bronner, K.K.4    Fisher, E.S.5
  • 37
    • 0013498104 scopus 로고
    • Product Quality Regulation and New Drug Introductions: Some New Evidence from the 1970s
    • Wiggins, S. N. (1981 Product Quality Regulation and New Drug Introductions: Some New Evidence from the 1970s Review of Economics and Statistics 63 : 615 619.
    • (1981) Review of Economics and Statistics , vol.63 , pp. 615-619
    • Wiggins, S.N.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.